Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Titration Calculations: Strong Acid - Strong Base

Titration Calculations: Strong Acid - Strong Base

Calculating pH for Titration Solutions: Strong Acid/Strong Base
A titration is carried out for 25.00 mL of 0.100 M HCl (strong acid) with 0.100 M of a strong base NaOH. The pH at different volumes of added base solution can be calculated as follows:
(a) Titrant volume = 0 mL. The solution pH is due to the acid ionization of HCl. Because this is a strong acid, the ionization is complete and the hydronium ion molarity is 0.100 M. The pH of the solution is then:

Strong Acid and Base Solutions

Strong Acid and Base Solutions

A strong acid is a compound that dissociates completely in an aqueous solution and produces a concentration of hydronium ions equal to the initial concentration of acid. For example, 0.20 M hydrobromic acid will dissociate completely in water and produces 0.20 M of hydronium ions and 0.20 M of bromide ions.

Titration of a Strong Acid with a Strong Base

Titration of a Strong Acid with a Strong Base

During the titration of a strong acid with a strong base, pH calculations are primarily based on the concentration of residual hydronium or hydroxide ions. Initially, a strong acid like hydrochloric acid fully dissociates, creating hydronium and chloride ions, resulting in a low pH. The addition of a strong base like sodium hydroxide alters the concentration of hydronium ions by neutralizing them. As more base is added, the pH gradually increases. At the equivalence point, all hydronium ions...

Titration Calculations: Weak Acid - Strong Base

Titration Calculations: Weak Acid - Strong Base

Calculating pH for Titration Solutions: Weak Acid/Strong Base
For the titration of 25.00 mL of 0.100 M CH3CO2H with 0.100 M NaOH, the reaction can be represented as:

Titration of a Weak Acid with a Strong Base

Titration of a Weak Acid with a Strong Base

In titrating a weak acid with a strong base, different calculation methods are applied at various stages. Initially, the pH of a weak acid like acetic acid is calculated using its dissociation constant (Ka) and an ICE table. Upon addition of a strong base such as sodium hydroxide, a buffer forms, and its pH is determined using the Henderson-Hasselbalch equation. As more base is added and the titration reaches the halfway point, the pH becomes equal to the pKa of the acid, indicating equal...

Titration of Polyprotic Acids with a Strong Base

Titration of Polyprotic Acids with a Strong Base

Titration of a polyprotic acid, which contains multiple ionizable protons, involves distinct dissociation steps, each with its own dissociation constant (Ka). Each successive Ka is weaker than the previous one. In the titration of a polyprotic acid like sulfurous acid with a strong base such as sodium hydroxide, the base first neutralizes the initial ionizable proton, forming an intermediate species (e.g., hydrogen sulfite ions). This step's titration curve resembles that of a weak...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Social determinants of vulnerability to nitrogen oxide- and sulfur dioxide-related bone damage among postmenopausal women in the United States.

Frontiers in public health·2026

Same author

Pharmacologic Treatments With Lifestyle Modifications in Nonpregnant Adults With Overweight or Obesity in Outpatient Settings: A Living Clinical Guideline From the American College of Physicians (April 2026).

Annals of internal medicine·2026

Same author

Annals On Call - Breast Cancer Screening: Guidance From the American College of Physicians.

Annals of internal medicine·2026

Same author

Associations of obesity phenotypes with incident fall rates: results from the objective physical activity and cardiovascular disease health in older women study.

The journals of gerontology. Series A, Biological sciences and medical sciences·2026

Same author

The association between 10-year cardiovascular risk and fracture incidence in postmenopausal women: a prospective analysis from the Women's Health Initiative.

Lancet regional health. Americas·2026

Same author

Forearm BMD predicts fracture independently of FRAX.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2026

Search research articles

Related Experiment Video

Updated: Jan 21, 2026

Synthesis of Strong Adhesive Hydrogel, Gelatin O-Nitrosobenzaldehyde

Synthesis of Strong Adhesive Hydrogel, Gelatin O-Nitrosobenzaldehyde

Published on: November 11, 2022

Strong Bones, Strong Body.

Carolyn J Crandall¹

¹Division of General Internal Medicine and Health Services Research, 1100 Glendon Ave., Suite 850-Room 858, Los Angeles, CA 90024, USA.

Obstetrics and Gynecology Clinics of North America

|August 6, 2019

Summary

Postmenopausal women should undergo bone density testing, with younger women needing risk assessment. Pharmacologic agents are available to treat osteoporosis, especially in women with prior fractures.

Area of Science:

Endocrinology
Geriatrics
Women's Health

Background:

Osteoporosis is a prevalent condition affecting postmenopausal women.
Bone health screening is crucial for early detection and intervention.

Purpose of the Study:

To outline screening recommendations for osteoporosis in women.
To highlight treatment options for diagnosed osteoporosis.

Main Methods:

Bone mineral density testing for women aged 65 and older.
Formal risk assessment tools for younger women to guide bone density testing decisions.
Review of available pharmacologic agents for osteoporosis treatment.

Main Results:

Specific age-based guidelines for bone mineral testing in women.

Keywords:

BMD Bone density DXA Dual-energy X-ray absorptiometry Fracture Osteoporosis

More Related Videos

Measurement of Ultrafast Vibrational Coherences in Polyatomic Radical Cations with Strong-Field Adiabatic Ionization

Measurement of Ultrafast Vibrational Coherences in Polyatomic Radical Cations with Strong-Field Adiabatic Ionization

Published on: August 6, 2018

Calvarial Model of Bone Augmentation in Rabbit for Assessment of Bone Growth and Neovascularization in Bone Substitution Materials

Calvarial Model of Bone Augmentation in Rabbit for Assessment of Bone Growth and Neovascularization in Bone Substitution Materials

Published on: August 13, 2019

Related Experiment Videos

Last Updated: Jan 21, 2026

Synthesis of Strong Adhesive Hydrogel, Gelatin O-Nitrosobenzaldehyde

Synthesis of Strong Adhesive Hydrogel, Gelatin O-Nitrosobenzaldehyde

Published on: November 11, 2022

Measurement of Ultrafast Vibrational Coherences in Polyatomic Radical Cations with Strong-Field Adiabatic Ionization

Measurement of Ultrafast Vibrational Coherences in Polyatomic Radical Cations with Strong-Field Adiabatic Ionization

Published on: August 6, 2018

Calvarial Model of Bone Augmentation in Rabbit for Assessment of Bone Growth and Neovascularization in Bone Substitution Materials

Calvarial Model of Bone Augmentation in Rabbit for Assessment of Bone Growth and Neovascularization in Bone Substitution Materials

Published on: August 13, 2019

Risk assessment as a strategy for determining bone density testing in younger populations.

Availability of multiple pharmacologic treatments for osteoporosis.

Conclusions:

Timely bone density testing and risk assessment are vital for postmenopausal women.
Pharmacotherapy is recommended for women with osteoporosis, particularly those with a history of fractures.